Building a Biotech Pipeline for Aesthetics and Therapeutics
Ep. 106 w/ Conor Gallagher of Revance
Aug 2024
With the stated goal of setting a "new standard in healthcare by elevating patient and physician experiences," Revance boasts an impressive lineup of aesthetic and therapeutic offerings. What's more, Daxxify was recently approved for FDA approved for the treatment of cervical dystonia in adults. And the future is looking even brighter with the recent announcement that Revance has entered into a merger agreement with Crown Laboratories to bring together their complementary product lines.
Watch Now